» Articles » PMID: 34672897

Erzhi Pills Ameliorate Cognitive Dysfunction and Alter Proteomic Hippocampus Profiles Induced by D-galactose and Aβ Injection in Ovariectomized Alzheimer's Disease Model Rats

Overview
Journal Pharm Biol
Specialties Pharmacology
Pharmacy
Date 2021 Oct 21
PMID 34672897
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Erzhi pills are a classic Chinese medicine prescription, but their effects on Alzheimer's disease (AD) are not clear.

Objective: The protective effects of Erzhi pills in AD rats and their potential mechanisms were investigated.

Materials And Methods: An AD rat model was established by ovariectomy combined with d-galactose and Aβ injection. Rats were randomly divided into five groups: sham-operated, model, oestradiol valerate (0.80 mg/kg), Erzhi pills high-dose (1.50 g/kg), and Erzhi pills low-dose (0.75 g/kg). Learning and memory abilities were evaluated with the Morris water maze test, oestrogen levels with an ELISA kit, and hippocampal neuron morphology and Nissl bodies in the cytoplasm with H&E and Nissl staining. The expression of ERβ, Aβ, and p-tau was determined by immunohistochemistry. Nano LC-LTQ-Orbitrap Proteomics determined potential targets and related signalling pathways. Western blotting was used to detect the expression of the related proteins.

Results: Erzhi pills (1.5, 0.75 g/kg) markedly reduced escape latencies on the MWM, increased numbers of platform crossings, numbers of neurons, Nissl bodies, oestrogen levels (100.18, 43.04 pg/mL), and ERβ-positive cells (57.42, 39.83); Aβ (18.85, 36.83)- and p-tau (14.42, 29.71)-positive cells were significantly decreased. Proteomics identified more than 100 differentially expressed proteins involved in 48 signalling pathways, five of which are involved in the PI3K/Akt signalling pathway. Western blotting showed decreased expression of GSK3β and Bad, while Akt, PI3K, 14-3-3, Bcl-xl, and Bcl-2 were upregulated.

Discussion And Conclusion: Erzhi pills may serve as a potential agent for AD therapeutics by improving learning and memory.

Citing Articles

The active components of Erzhi wan and their anti-Alzheimer's disease mechanisms determined by an integrative approach of network pharmacology, bioinformatics, molecular docking, and molecular dynamics simulation.

Yu M, Shen Z, Zhang S, Zhang Y, Zhao H, Zhang L Heliyon. 2024; 10(13):e33761.

PMID: 39027618 PMC: 11255520. DOI: 10.1016/j.heliyon.2024.e33761.


A review of botany, phytochemistry, pharmacology, and applications of the herb with the homology of medicine and food: W.T. Aiton.

Chen L, Huang D, Jiang L, Yang J, Shi X, Wang R Front Pharmacol. 2024; 15:1330732.

PMID: 38933667 PMC: 11199554. DOI: 10.3389/fphar.2024.1330732.


Erzhiwan Ameliorates Restraint Stress- and Monobenzone-Induced Depigmentation in Mice by Inhibiting Macrophage Migration Inhibitory Factor and 8-Hydroxy-2-Deoxyguanosine.

Tang N, Liu X, Lin X, Yang W, Li Q, Wang G Clin Cosmet Investig Dermatol. 2024; 17:147-158.

PMID: 38283796 PMC: 10812780. DOI: 10.2147/CCID.S420385.


Attenuation of estrogen and its receptors in the post-menopausal stage exacerbates dyslipidemia and leads to cognitive impairment.

Meng Q, Chao Y, Zhang S, Ding X, Feng H, Zhang C Mol Brain. 2023; 16(1):80.

PMID: 37986006 PMC: 10662842. DOI: 10.1186/s13041-023-01068-0.


Promotion of Hair Regrowth in Androgenetic Alopecia with Supplemented Erzhi Wan: Exploring Its Mechanism Using Network Pharmacology and Molecular Docking.

Ji C, Ma J, Feng C, Zhu H, Gao Y, Huang J Clin Cosmet Investig Dermatol. 2023; 16:2995-3022.

PMID: 37901149 PMC: 10612515. DOI: 10.2147/CCID.S425295.


References
1.
Bove R, Secor E, Chibnik L, Barnes L, Schneider J, Bennett D . Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2013; 82(3):222-9. PMC: 3902759. DOI: 10.1212/WNL.0000000000000033. View

2.
Gao H, Wang D, Wang X, Wang Z, Wang X, Wu Z . Effect of Erzhi Pill (二至丸) on improving cerebral nerve cell apoptosis in aging rats. Chin J Integr Med. 2010; 16(6):504-9. DOI: 10.1007/s11655-010-0565-2. View

3.
Wu J, Wang Y, Zhang Z, Yu B . Herbal medicine in the treatment of Alzheimer's disease. Chin J Integr Med. 2014; 21(2):102-7. DOI: 10.1007/s11655-014-1337-y. View

4.
Li L, Zhang L, Yang C . Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer's Disease Therapy. Curr Top Med Chem. 2015; 16(5):537-48. DOI: 10.2174/1568026615666150813144003. View

5.
Walton J . Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment. Int J Alzheimers Dis. 2012; 2012:914947. PMC: 3423924. DOI: 10.1155/2012/914947. View